Pfizer (PFE) Current Taxes (2009 - 2026)
Pfizer (PFE) posted quarterly Current Taxes of $3.1 billion for Q1 2026, up 0.81% year-over-year from $3.1 billion in Q1 2025, and up 0.87% quarter-over-quarter from $3.1 billion in Q4 2025.
Pfizer (PFE) Current Taxes (2009 - 2026) Analysis & Trends
Pfizer (PFE) has reported Current Taxes for 18 consecutive years, with $3.1 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Taxes rose 0.81% year-over-year to $3.1 billion; the TTM figure through Mar 2026 stood at $3.1 billion (up 0.81% YoY), while the FY2025 annual figure was $3.1 billion, up 6.63% from the prior year.
- Current Taxes grew to $3.1 billion in Q1 2026 per PFE's latest filing, from $3.1 billion in the prior quarter.
- Across five years, Current Taxes topped out at $3.8 billion in Q3 2025 and bottomed at $1.6 billion in Q4 2022.
- Historically, Current Taxes has averaged $2.9 billion across 5 years, with a median of $3.1 billion in 2025.
- Annual changes were most pronounced in 2022 — Current Taxes jumped 126.77% — and 2023, when it plunged 38.02%.
- Pfizer's Current Taxes stood at $1.6 billion in 2022, then surged by 48.02% to $2.3 billion in 2023, then gained by 23.88% to $2.9 billion in 2024, then rose by 6.63% to $3.1 billion in 2025, then gained by 0.87% to $3.1 billion in 2026.
- Business Quant data shows PFE's Current Taxes at $3.1 billion in Q1 2026, $3.1 billion in Q4 2025, and $3.8 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 1.05 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | - |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | 4.22 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 2.31 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 1.47 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | - |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 653.00 Mn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | -703.04 Mn |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 1.03 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | 653.00 Mn |
| Mar 29, 2026 | 3.13 Bn |
| Dec 31, 2025 | 3.10 Bn |
| Sep 28, 2025 | 3.80 Bn |
| Jun 29, 2025 | 3.68 Bn |
| Mar 30, 2025 | 3.11 Bn |
| Dec 31, 2024 | 2.91 Bn |
| Sep 29, 2024 | 2.88 Bn |
| Jun 30, 2024 | 2.88 Bn |
| Mar 31, 2024 | 3.19 Bn |
| Dec 31, 2023 | 2.35 Bn |
| Jul 2, 2023 | 2.93 Bn |
| Apr 2, 2023 | 1.97 Bn |
| Dec 31, 2022 | 1.59 Bn |
| Jul 3, 2022 | 3.35 Bn |
| Apr 3, 2022 | 3.18 Bn |
| Dec 31, 2021 | 1.27 Bn |
| Oct 3, 2021 | 4.50 Bn |
| Jul 4, 2021 | 1.74 Bn |
| Apr 4, 2021 | 1.40 Bn |